Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

166.98 -1.64 (-0.97%)
Streaming Delayed Price Updated: 1:06 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novartis AG Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
42 43 Next >
News headline image
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies ↗
Tuesday, the FDA said it received reports of patients developing T-cell malig 
Via Benzinga
News headline image
3 Healthcare Stocks to Pick Up Before the Year-End Rally ↗
Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending 
Via InvestorPlace
News headline image
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off ↗
Novartis AG (NYSE: NVS) has outlined the progress made in delivering its pure-play strategy, focused on four core therapeutic areas (Cardiovascular-Renal-Metabolic, Immunology, Neuroscience, Oncology),... 
Via Benzinga
News headline image
Olema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued. ↗
The company is working on treatments for breast cancer in a market worth $15 billion, according to the CEO. 
Via Investor's Business Daily
News headline image
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal ↗
Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and... 
Via Talk Markets
News headline image
How Is The Market Feeling About Novartis? ↗
 
Via Benzinga
News headline image
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
News headline image
Novartis Hikes Its Earnings Outlook For The Third Time This Year ↗
The company also beat third-quarter expectations after spinning off its Sandoz unit. 
Via Investor's Business Daily
News headline image
Diversifying Your Portfolio With Plant-Based Options ↗
Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market... 
Via Talk Markets
News headline image
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On ↗
Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector. 
Via The Motley Fool
News headline image
Verve Loses A Third Of Its Value As Safety Concerns Plague Its Gene-Editing Drug ↗
Patients had big decreases in LDL cholesterol. But there were some side effects. 
Via Investor's Business Daily
News headline image
3 Spectacular High-Yield Dividend Stocks to Buy in November ↗
Income investors should find plenty to like with these stocks. 
Via The Motley Fool
News headline image
Novartis' Rare Kidney Disease Candidate Aces Late-Stage Study ↗
Novartis AG (NYSE: NVS) released topline results from the interim analysis of the ongoing pivotal Phase 3 ALIGN study of atrasentan in patients with IgA nephropathy (IgAN).  IgAN is a major cause of... 
Via Benzinga
News headline image
Earnings Outlook For Novartis ↗
 
Via Benzinga
News headline image
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More ↗
The U.S. 
Via Benzinga
News headline image
3 No-Brainer Stocks to Buy for Under $100 Right Now ↗
A couple of these stocks might not be available for under $100 for too much longer. 
Via The Motley Fool
News headline image
2 Green Flags and 1 Red Flag for Novartis Stock ↗
The Swiss pharmaceutical company just posted strong Q3 numbers and is going through some big changes. 
Via The Motley Fool
News headline image
7 Undervalued Stocks to Buy Before Everyone Else ↗
Buy these undervalued stocks while they trade at a significant discount compared to their intrinsic valuations. 
Via InvestorPlace
News headline image
Sanofi Stock Relative Strength Rating Jumps To 84: One To Watch ↗
Additionally, Sanofi stock has a decent 83 Composite Rating out of 99, and an 80 Earnings Per Share Rating. 
Via Investor's Business Daily
News headline image
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript ↗
NVS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Avenue Z Hires Leading Digital Media and Technology Executive David Corchado to Lead Team in Global Strategy
--News Direct-- 
Via News Direct
News headline image
US Stock Futures Surge Ahead Of Microsoft, Google Earnings: Analyst Says 'Magnificent Seven' Unlikely To See Tesla-Like Volatility After Results ↗
Buoyed by earnings optimism, stocks appear on track for a positive open on Tuesday after the tech-heavy Nasdaq Composite Index snapped a four-day losing streak in the previous session. The uptick in... 
Via Benzinga
Topics Bonds Stocks
News headline image
Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More ↗
Novartis AG (NYSE: NVS) reported  
Via Benzinga
Topics Earnings
News headline image
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
Via Benzinga
Topics Stocks
News headline image
7 Healthcare Stocks to invest in for a Healthy Future ↗
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners. 
Via InvestorPlace
News headline image
2 Biotech Stocks That Could Make You Richer ↗
These two well-known drugmakers still have some growth fuel in their seemingly empty tanks. 
Via The Motley Fool
News headline image
3 Unstoppable Stocks to Buy and Hold for Decades ↗
These stocks can be pillars for your long-term portfolio, and investing in all three offers excellent diversification. 
Via The Motley Fool
News headline image
Why Top 1% Biotech MoonLake Just Surged Within Striking Distance Of A Breakout ↗
MoonLake says it's skin-disease treatment showed improved promise in a 24-week testing update. 
Via Investor's Business Daily
News headline image
RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan ↗
JP Morgan has initiated coverage on RayzeBio Inc (NASDAQ: RYZB), representing a pure-play opportunity in the radiopharmaceutical space. 
Via Benzinga
News headline image
AbbVie Stock Moves Higher With Rising Relative Strength ↗
A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Will it continue? 
Via Investor's Business Daily
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.